J.-M. Freyssinet

1.1k total citations
24 papers, 724 citations indexed

About

J.-M. Freyssinet is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J.-M. Freyssinet has authored 24 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 7 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J.-M. Freyssinet's work include Blood Coagulation and Thrombosis Mechanisms (12 papers), Blood properties and coagulation (4 papers) and Platelet Disorders and Treatments (4 papers). J.-M. Freyssinet is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (12 papers), Blood properties and coagulation (4 papers) and Platelet Disorders and Treatments (4 papers). J.-M. Freyssinet collaborates with scholars based in France, Switzerland and United Kingdom. J.-M. Freyssinet's co-authors include J. Torbet, G Hudry-Clergeon, Jean‐Pierre Cazenave, Alain Beretz, C Klein-Soyer, B. Hugel, Christine Brisson, Florence Toti, Dominique Meyer and J. John Holbrook and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Biochemistry.

In The Last Decade

J.-M. Freyssinet

24 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-M. Freyssinet France 15 282 204 107 79 74 24 724
Benjamin Brenner Israel 15 387 1.4× 328 1.6× 52 0.5× 109 1.4× 180 2.4× 27 901
J.L.M.L. van Rijn Netherlands 9 388 1.4× 270 1.3× 129 1.2× 79 1.0× 113 1.5× 14 836
Corinne Kunzelmann France 11 144 0.5× 853 4.2× 130 1.2× 205 2.6× 68 0.9× 15 1.3k
Suzanne Lyman United States 20 711 2.5× 548 2.7× 181 1.7× 332 4.2× 85 1.1× 31 1.9k
Guido Tans Netherlands 18 977 3.5× 266 1.3× 136 1.3× 91 1.2× 84 1.1× 29 1.5k
Bin Hu China 14 249 0.9× 327 1.6× 186 1.7× 103 1.3× 211 2.9× 68 1.1k
Stacey A. Snyder United States 12 56 0.2× 202 1.0× 100 0.9× 64 0.8× 29 0.4× 16 776
Mei‐Kwan Yau Australia 16 393 1.4× 392 1.9× 32 0.3× 266 3.4× 66 0.9× 26 1.1k
D. Yu. Nechipurenko Russia 13 233 0.8× 232 1.1× 149 1.4× 42 0.5× 111 1.5× 43 642
Alicia J. Schade United States 10 955 3.4× 234 1.1× 173 1.6× 517 6.5× 193 2.6× 11 1.4k

Countries citing papers authored by J.-M. Freyssinet

Since Specialization
Citations

This map shows the geographic impact of J.-M. Freyssinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-M. Freyssinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-M. Freyssinet more than expected).

Fields of papers citing papers by J.-M. Freyssinet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-M. Freyssinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-M. Freyssinet. The network helps show where J.-M. Freyssinet may publish in the future.

Co-authorship network of co-authors of J.-M. Freyssinet

This figure shows the co-authorship network connecting the top 25 collaborators of J.-M. Freyssinet. A scholar is included among the top collaborators of J.-M. Freyssinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-M. Freyssinet. J.-M. Freyssinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morel, Olivier, Florence Toti, & J.-M. Freyssinet. (2007). Marqueurs des pathologies thrombotiques. Annales Pharmaceutiques Françaises. 65(2). 75–84. 10 indexed citations
2.
3.
Morel, Olivier, N. Morel, B. Hugel, et al.. (2005). Les microparticules circulantes : rôles physiologiques et implications dans les maladies inflammatoires et thrombotiques. La Revue de Médecine Interne. 26(10). 791–801. 27 indexed citations
4.
Hugel, B., et al.. (2004). Modulation of signal transduction through the cellular prion protein is linked to its incorporation in lipid rafts. Cellular and Molecular Life Sciences. 61(23). 2998–3007. 42 indexed citations
5.
Boyer‐Neumann, Catherine, M. Wolf, B. Hugel, et al.. (2001). Circulating Procoagulant Microparticles in Women with Unexplained Pregnancy Loss: a New Insight. Thrombosis and Haemostasis. 85(1). 18–21. 87 indexed citations
6.
7.
Satta, Nathalie, Florence Toti, E Fressinaud, Dominique Meyer, & J.-M. Freyssinet. (1997). Scott syndrome: an inherited defect of the procoagulant activity of platelets. Platelets. 8(2-3). 117–124. 29 indexed citations
8.
Eschwège, Valérie & J.-M. Freyssinet. (1996). The possible contribution of cell apoptosis and necrosis to the generation of phospholipid-binding antibodies.. PubMed. 147 Suppl 1. 33–5. 1 indexed citations
9.
Lecompte, M.F., F. Bardou, Frédéric Rodriguez, & J.-M. Freyssinet. (1995). Effect of phospholipid membranes on α-thrombin activity. Bioelectrochemistry and Bioenergetics. 38(1). 105–109. 1 indexed citations
10.
Grunebaum, L., Ronald A. Asherson, J.-M. Freyssinet, et al.. (1992). Anticorps antiphospholipides (aPL): détection et signification clinique. La Revue de Médecine Interne. 13(4). 307–314. 3 indexed citations
11.
Siè, Piérre, Annie Bezeaud, D. Dupouy, et al.. (1991). An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.. Journal of Clinical Investigation. 88(1). 290–296. 17 indexed citations
12.
Freyssinet, J.-M., et al.. (1991). The catalytic role of anionic phospholipids in the activation of protein C by factor Xa and expression of its anticoagulant function in human plasma. Blood Coagulation & Fibrinolysis. 2(6). 691–691. 16 indexed citations
13.
Ireland, H., David A. Lane, Elizabeth Thompson, et al.. (1991). Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin. British Journal of Haematology. 79(1). 70–74. 28 indexed citations
14.
Grunebaum, L., Ronald A. Asherson, J.-M. Freyssinet, & Jean‐Pierre Cazenave. (1991). Déficits congénitaux dans les systèmes anticoagulants naturels responsables de maladies thromboemboliques récidivantes. La Revue de Médecine Interne. 12(1). 37–41. 2 indexed citations
15.
Lane, David A., Elizabeth Thompson, R.J. Olds, et al.. (1991). Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate. British Journal of Haematology. 77(1). 87–92. 39 indexed citations
16.
17.
Torbet, J. & J.-M. Freyssinet. (1987). Neutron scattering determination of the binding of prothrombin to lipid vesicles. Biochemistry. 26(24). 7791–7798. 7 indexed citations
18.
Torbet, J., J.-M. Freyssinet, & G Hudry-Clergeon. (1981). Oriented fibrin gels formed by polymerization in strong magnetic fields. Nature. 289(5793). 91–93. 174 indexed citations
19.
Lewis, Barbara, J.-M. Freyssinet, & J. John Holbrook. (1978). An equilibrium study of metal ion binding to human plasma coagulation factor XIII. Biochemical Journal. 169(2). 397–402. 23 indexed citations
20.
Freyssinet, J.-M., Barbara Lewis, J. John Holbrook, & Joseph D. Shore. (1978). Protein-protein interactions in blood clotting. The use of polarization of fluorescence to measure the dissociation of plasma factor XIIIa. Biochemical Journal. 169(2). 403–410. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Brenner Breakdown of academic impact, for papers by J.L.M.L. van Rijn Breakdown of academic impact, for papers by Corinne Kunzelmann Breakdown of academic impact, for papers by Suzanne Lyman Breakdown of academic impact, for papers by Guido Tans Breakdown of academic impact, for papers by Bin Hu Breakdown of academic impact, for papers by Stacey A. Snyder Breakdown of academic impact, for papers by Mei‐Kwan Yau Breakdown of academic impact, for papers by D. Yu. Nechipurenko Breakdown of academic impact, for papers by Alicia J. Schade
Rankless by CCL
2026